Bastide Le Confort Médical SA (0IP1.L)
EUR 23.85
(-0.63%)
EUR 23.85
(-0.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 529.75 Million EUR | 4.28% |
| 2023 | 508.03 Million EUR | 8.48% |
| 2022 | 468.3 Million EUR | 5.46% |
| 2021 | 444.07 Million EUR | 16.04% |
| 2020 | 382.7 Million EUR | 13.99% |
| 2019 | 335.73 Million EUR | 16.15% |
| 2018 | 289.05 Million EUR | 32.53% |
| 2017 | 218.1 Million EUR | 13.69% |
| 2016 | 191.85 Million EUR | 12.08% |
| 2015 | 171.16 Million EUR | 12.51% |
| 2014 | 152.13 Million EUR | 13.49% |
| 2013 | 134.05 Million EUR | 8.48% |
| 2012 | 123.57 Million EUR | 13.23% |
| 2011 | 109.13 Million EUR | 9.18% |
| 2010 | 99.95 Million EUR | 3.26% |
| 2009 | 96.79 Million EUR | 2.06% |
| 2008 | 94.84 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 265.02 Million EUR | 0.0% |
| 2024 Q4 | 264.73 Million EUR | 0.0% |
| 2023 Q2 | 249.73 Million EUR | 0.0% |
| 2023 FY | 508.03 Million EUR | 8.48% |
| 2023 Q4 | 258.29 Million EUR | 0.0% |
| 2022 FY | 468.3 Million EUR | 5.46% |
| 2022 Q4 | 245.2 Million EUR | 0.0% |
| 2022 Q2 | 223.09 Million EUR | 0.0% |
| 2021 Q4 | 222.4 Million EUR | 0.0% |
| 2021 Q2 | 221.66 Million EUR | 0.0% |
| 2021 FY | 444.07 Million EUR | 16.04% |
| 2020 Q2 | 176.64 Million EUR | 0.0% |
| 2020 Q4 | 206.06 Million EUR | 0.0% |
| 2020 FY | 382.7 Million EUR | 13.99% |
| 2019 Q4 | 169.92 Million EUR | 0.0% |
| 2019 FY | 335.73 Million EUR | 16.15% |
| 2019 Q2 | 165.8 Million EUR | 0.0% |
| 2018 FY | 289.05 Million EUR | 32.53% |
| 2018 Q4 | 155.34 Million EUR | 0.0% |
| 2018 Q2 | 133.7 Million EUR | 0.0% |
| 2017 Q2 | 106.47 Million EUR | 0.0% |
| 2017 FY | 218.1 Million EUR | 13.69% |
| 2017 Q4 | 111.63 Million EUR | 0.0% |
| 2016 FY | 191.85 Million EUR | 12.08% |
| 2016 Q2 | 95.07 Million EUR | 0.0% |
| 2016 Q4 | 96.77 Million EUR | 0.0% |
| 2015 FY | 171.16 Million EUR | 12.51% |
| 2015 Q2 | 83.85 Million EUR | 0.0% |
| 2015 Q4 | 87.3 Million EUR | 0.0% |
| 2014 FY | 152.13 Million EUR | 13.49% |
| 2014 Q4 | 76.56 Million EUR | 0.0% |
| 2014 Q2 | 75.56 Million EUR | 0.0% |
| 2013 Q4 | 67.81 Million EUR | 0.0% |
| 2013 Q2 | 66.23 Million EUR | 0.0% |
| 2013 FY | 134.05 Million EUR | 8.48% |
| 2012 Q4 | 30.89 Million EUR | 0.0% |
| 2012 Q3 | 30.89 Million EUR | 0.0% |
| 2012 FY | 123.57 Million EUR | 13.23% |
| 2012 Q2 | 30.89 Million EUR | 13.23% |
| 2012 Q1 | 27.28 Million EUR | 0.0% |
| 2011 Q1 | 24.98 Million EUR | 0.0% |
| 2011 Q2 | 27.28 Million EUR | 9.18% |
| 2011 Q3 | 27.28 Million EUR | 0.0% |
| 2011 Q4 | 27.28 Million EUR | 0.0% |
| 2011 FY | 109.13 Million EUR | 9.18% |
| 2010 Q3 | 24.98 Million EUR | 0.0% |
| 2010 Q4 | 24.98 Million EUR | 0.0% |
| 2010 Q2 | 24.98 Million EUR | 3.26% |
| 2010 FY | 99.95 Million EUR | 3.26% |
| 2010 Q1 | 24.19 Million EUR | 0.0% |
| 2009 Q4 | 24.19 Million EUR | 0.0% |
| 2009 Q3 | 24.19 Million EUR | 0.0% |
| 2009 Q2 | 24.19 Million EUR | 2.06% |
| 2009 Q1 | 23.71 Million EUR | 0.0% |
| 2009 FY | 96.79 Million EUR | 2.06% |
| 2008 FY | 94.84 Million EUR | 0.0% |
| 2008 Q4 | 23.71 Million EUR | 0.0% |
| 2008 Q3 | 23.71 Million EUR | 0.0% |
| 2008 Q2 | 23.71 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Cegedim SA | 615.99 Million EUR | 14.0% |
| Guerbet SA | 795.65 Million EUR | 33.419% |
| Nexus AG | 241.45 Million EUR | -119.397% |
| Revenio Group Oyj | 96.57 Million EUR | -448.537% |
| Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 84.297% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 84.399% |
| LNA Santé SA | 736.08 Million EUR | 28.031% |
| Siemens Healthineers AG | 22.36 Billion EUR | 97.631% |
| Medios AG | 1.78 Billion EUR | 70.317% |
| Equasens Société anonyme | 219.78 Million EUR | -141.03% |
| Stratec SE | 261.91 Million EUR | -102.265% |